Watson Pharmaceuticals, Inc. (NYSE: WPI) is a leading integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, brand and biologic pharmaceutical products.

We operate and manage our business as three operating segments: Global Generics, Global Brands and Anda Distribution. Our largest commercial market is the United States, followed by our key international markets including Western Europe, Canada, Asia/Pacific, South America and South Africa.

As of December 31, 2010 we marketed approximately 160 generic prescription pharmaceutical product families and more than 30 brand pharmaceutical product families in the U.S., and a significant number of product families internationally. Our Anda Distribution Division distributes products for over 200 suppliers and is focused on providing next-day delivery and responsive service to its customers.